Welcome to the Office of Cancer Survivorship Program, DCCPS
The NCI Office of Cancer Survivorship (OCS) works to enhance the quality and length of survival of all persons diagnosed with cancer and to prevent, minimize, or manage adverse effects of cancer and its treatment.
Pre-Application Webinar – RFA-CA-23-025: Addressing the Primary Care Needs of Cancer Survivors
March 2023 – This webinar on Wednesday, March 29, 2023, from 2-3 p.m. ET will provide an overview of RFA-CA-23-025 and the application process, as well as an opportunity for questions from the investigator community. Please register now.
OCS Director's Series presents Cancer Information Online: Misinformation and Other Pitfalls for Cancer Survivors
March 2023 – Join the Office of Cancer Survivorship for this upcoming OCS Director’s Series webinar on March 21, 2023, from 2-3 p.m. ET. Dr. Stacy Loeb will present Cancer Information Online: Misinformation and Other Pitfalls for Cancer Survivors. Register now.
OCS Director's Series presents Improving Care for Cancer Survivors with Serious Mental Illness
April 2023 – Register now for this upcoming OCS Director’s Series webinar. On April 25, 2023, from 2-3 p.m. ET, Dr. Kelly Irwin will present Improving Care for Cancer Survivors with Serious Mental Illness.
Special Section: Hearing Loss in Cancer Survivorship
February 2023 – OCS Director Dr. Emily Tonorezos co-leads this recent special section in the Journal of Cancer Survivorship focused on treatment-induced hearing loss, or ototoxity.
About The Office of Cancer Survivorship
An individual is considered a cancer survivor from the time of diagnosis, through the balance of life. There are many types of survivors, including those living with cancer and those free of cancer. This term is meant to capture a population of those with a history of cancer rather than to provide a label that may or may not resonate with individuals.
OCS works to promote a better understanding of unique needs of the growing population of cancer survivors, and to enhance our ability to address them.
Featured Graph and Statistic
Individuals Living with Metastatic Cancer
Researchers at the National Cancer Institute have estimated that 623,405 people in the United States were living with metastatic breast, prostate, lung, colorectal, or bladder cancer or metastatic melanoma as of 2018, and that number is expected to increase to 693,452 by the year 2025.
Cancer Survivor Statistics
It is estimated that there are 18.1 million cancer survivors in the United States. This represents approximately 5.4% of the population.